Status:
WITHDRAWN
Assessment of Fit of Novel N95 Style Transparent Face Masks
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Respiratory Disease
Infection, Coronavirus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Face masks have become a critically important public health intervention after the COVID-19 pandemic. Multiple types of masks ranging from full face filtering to cloth masks have been developed and co...
Detailed Description
This is a randomized crossover trial to evaluate the feasibility, acceptability and choice between the use of the SEEUS-95, CrystalGuard transparent face masks or a standard N95 mask. Otherwise health...
Eligibility Criteria
Inclusion
- \>18 years old
- No history of asthma, restrictive lung disease, interstitial lung disease, or emphysema
- Lack of significant facial hair that precludes wearing a N-95 mask
Exclusion
- Less than 18 years old
- Unable to smell Bitrex solution used for fit testing
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06570161
Start Date
October 1 2024
End Date
May 30 2025
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115